Can You Drink Alcohol While Taking Ivermectin?

No official contraindication prohibits drinking alcohol while taking ivermectin, and the small amount of direct research on the combination has not flagged acute danger at standard doses. A pilot study that deliberately gave participants both ivermectin and an intoxicating dose of alcohol found no increase in adverse effects compared to placebo. That said, the two substances share overlapping biological pathways in ways that give pharmacologists pause, and the reassuring evidence comes from only a handful of studies with limited sample sizes. For most people taking a single prescribed dose of ivermectin for a parasitic infection, a drink or two is unlikely to cause a medical emergency, but there are real reasons to be cautious, and some people face higher risk than others.

What the Direct Evidence Actually Shows

Only two studies have looked squarely at what happens when ivermectin and alcohol are consumed together. The first was conducted in an area where ivermectin is used for mass drug administration against river blindness. Researchers gave participants ivermectin alongside a local alcoholic beverage and measured blood levels of the drug over the following hours. Co-administration of the alcoholic drink did not raise ivermectin plasma levels above what was seen in fasting participants. At the two-hour mark, participants who drank alcohol actually had slightly lower ivermectin levels than those who ate food or fasted, though overall pharmacokinetic measures like peak concentration and total drug exposure were not significantly different across groups.¹

The second study was a pilot trial investigating whether ivermectin might itself be useful in treating alcohol use disorder, based on its effects on certain brain receptors. Participants received 30 mg of oral ivermectin daily and were then given alcohol to the point of intoxication. The researchers found that ivermectin did not increase the number or severity of adverse effects during or after alcohol consumption compared to placebo.² The 30 mg dose used in that trial is notably higher than the standard antiparasitic dose, which typically falls around 0.15 to 0.2 mg per kilogram of body weight, so this is somewhat reassuring. Still, pilot studies are small by design, and “we didn’t see problems in a handful of participants” is not the same as “this combination is safe for everyone.”

They Share the Same Liver Enzyme

Ivermectin is broken down almost entirely by a single liver enzyme called CYP3A4. When researchers tested ivermectin against a panel of different liver enzymes, metabolic activity was detected only with CYP3A4, making it the predominant pathway.³ Follow-up work confirmed that the major metabolites found in human blood after an oral dose are all produced primarily by this enzyme.⁴

Alcohol is not metabolized by CYP3A4 itself; the body handles alcohol mainly through a different enzyme. But chronic heavy drinking changes the landscape of the liver’s enzyme machinery in ways that ripple out to CYP3A4. Regular alcohol consumption ramps up production of an enzyme called CYP2E1. Research using liver samples from people with a history of heavy alcohol use has shown that the increased CYP2E1 can cause a multifold activation of CYP3A4’s activity, dramatically altering how fast it processes drugs.⁵ In one set of experiments, liver microsomes from an alcoholic donor showed a maximal metabolic rate roughly ten times higher than a non-alcoholic sample with a comparable fraction of CYP3A4, alongside changes in the enzyme’s cooperative behavior.

What does this mean in practice? If you are a chronic heavy drinker, your liver may chew through ivermectin much faster than expected, potentially reducing the drug’s effectiveness against your parasite. Conversely, if something else is simultaneously inhibiting CYP3A4, like certain medications including some antifungals and HIV drugs, adding alcohol to the mix could create unpredictable swings in how much active ivermectin is circulating. The concern is less about a single glass of wine and more about the compounding effects when the liver’s enzyme balance is already altered by long-term drinking habits.

The Blood-Brain Barrier Question

Ivermectin works against parasites by binding to certain channels in their nervous systems and paralyzing them. Mammals have similar channels in their own brains, but under normal circumstances, very little ivermectin reaches the brain. The gatekeeper is a protein called P-glycoprotein, which sits on the surface of the cells lining the brain’s blood vessels and actively pumps ivermectin back out before it can cross into brain tissue.⁶ This pump is so effective that in animals with a genetic defect disabling it, ivermectin accumulates in the brain and causes severe neurotoxicity and even death.⁷

Alcohol can compromise this barrier. Experiments using human brain microvascular endothelial cells, the cells that form the blood-brain barrier, found that exposure to ethanol or its metabolite acetaldehyde reduced barrier tightness, increased permeability, and enhanced the movement of cells across the barrier.⁸ This did not involve ivermectin directly, and the exposures were prolonged rather than a single evening out. But the theoretical concern is straightforward: if alcohol weakens the barrier that normally keeps ivermectin out of the brain, more ivermectin could reach neural tissue, raising the odds of neurotoxic effects. Whether a few drinks produce enough barrier disruption to matter in a person taking a standard dose of ivermectin has not been studied, and may never be, since the combination is hard to justify as a controlled experiment in healthy volunteers.

Overlapping Effects on Brain Signaling

Both ivermectin and alcohol enhance the activity of GABA, the brain’s main inhibitory signaling molecule. GABA normally dampens neural activity, which is why drugs that boost GABA tend to cause sedation, relaxation, and at high enough levels, loss of coordination and consciousness. Alcohol is one of the most well-known GABA enhancers. Ivermectin, while primarily designed to act on parasite nervous systems, also potentiates mammalian GABA receptor activity. Laboratory measurements have shown that ivermectin can potentiate the action of GABA on receptors by several hundred percent relative to GABA alone.⁹

Under normal conditions, the blood-brain barrier keeps enough ivermectin out that this receptor interaction does not produce noticeable sedation in most people. But combining two substances that both push GABA activity in the same direction creates the kind of pharmacological overlap that makes toxicologists uncomfortable. If even a small amount of additional ivermectin reaches the brain because of barrier disruption or genetic variation in P-glycoprotein, the sedative effect of alcohol could be amplified in ways that feel disproportionate to the amount consumed. Some patients taking ivermectin report dizziness, drowsiness, or confusion even without alcohol. Adding a GABA-enhancing substance on top raises the floor for those effects.

Liver Injury Is Rare but Real

Ivermectin is generally well tolerated, and liver problems from it are uncommon. But they are documented. The first published case of severe ivermectin-induced hepatitis involved a 20-year-old woman who developed liver inflammation a month after a single dose taken for a parasitic infection. A liver biopsy showed inflammatory infiltrates and tissue death consistent with drug-induced liver disease.¹⁰ A broader pharmacovigilance study drawing on a global safety database found that out of nearly 1,400 reports associated with ivermectin, about 4% were classified as serious. Among cases where ivermectin had been used for COVID-19, a subset involved hepatic disorders including hepatitis, cholestasis, and elevated liver enzymes.¹¹ A separate case report with liver biopsy confirmed a pattern of injury scored as highly probable for a drug-induced cause.¹²

Alcohol, of course, is one of the most common causes of liver damage worldwide. Combining a drug that can occasionally stress the liver with a substance that reliably stresses it is not ideal. If you already have any degree of liver disease, whether from alcohol, hepatitis, fatty liver, or another cause, the liver’s capacity to safely process ivermectin may be reduced. For someone with a healthy liver taking a single standard dose of ivermectin, a moderate amount of alcohol is unlikely to tip the balance into liver injury. But anyone with compromised liver function has less margin for error, and their healthcare provider should know about their drinking habits before ivermectin is prescribed.

Who Faces the Most Risk

The combination is not equally risky for everyone. A few groups have more reason to be careful:

Heavy or chronic drinkers: Altered CYP3A4 activity from long-term alcohol use could change how fast ivermectin is metabolized, potentially reducing its effectiveness or, in combination with other factors, altering its safety profile.
People with liver disease: A liver already under stress from any cause has less capacity to handle additional insults from either ivermectin or alcohol.
People taking other CYP3A4-interacting medications: If you are on drugs that inhibit CYP3A4 (certain antifungals, HIV protease inhibitors, some antibiotics), ivermectin levels could be higher than usual. Adding alcohol to that picture compounds the uncertainty.
People with P-glycoprotein genetic variants: Genetic differences in the P-glycoprotein transporter can alter how much ivermectin reaches the brain. A review of ivermectin toxicity noted that genetic polymorphisms in P-glycoprotein may increase neurotoxicity.¹³ Most people do not know their P-glycoprotein status, which is part of the problem.
People taking higher-than-standard doses: Toxicity reports have risen with the use of veterinary formulations and off-label dosing. Patients taking veterinary products tended to take higher doses and had higher rates of altered mental status.¹⁴ Adding alcohol on top of an already-elevated dose would compound the central nervous system risks.

Practical Guidance When There Is No Official Rule

The reason you will not find a clear “do not drink” warning on ivermectin’s prescribing label is that no large, controlled study has shown the combination to be dangerous at standard doses. The pilot study that combined ivermectin with alcohol to the point of intoxication did not see problems.² The pharmacokinetic study with a local alcoholic brew found no meaningful changes in drug levels.¹ But “no large study has shown harm” is different from “safety has been established.” The combination has simply not been studied with the rigor that would be needed to issue a firm all-clear.

If you are taking a single standard dose of ivermectin for something like scabies or a roundworm infection, having a beer or glass of wine is very unlikely to cause a serious interaction. The drug is typically taken once and cleared within a couple of days. Most physicians would not object to light drinking in that scenario. Where caution becomes more warranted is with repeated dosing, higher-than-standard doses, pre-existing liver problems, or heavy drinking patterns. In those situations, the overlapping mechanisms described above stop being theoretical curiosities and start looking like genuine risk multipliers.

Why Ivermectin Side Effects Can Look Like a Hangover

One underappreciated wrinkle is that ivermectin’s own side effects overlap with symptoms of alcohol intoxication or a hangover, which makes it hard to tell what is causing what. Common adverse effects of ivermectin include dizziness, nausea, headache, and fatigue. After drinking, those same symptoms could easily be attributed to the alcohol rather than the drug. In cases of ivermectin toxicity, neurotoxic effects such as altered mental status, confusion, and coordination problems have been reported.¹⁴ If someone who has been drinking experiences these symptoms, they might chalk it up to one too many drinks and miss signs that they are having a drug reaction requiring medical attention.

This diagnostic confusion is a practical reason to separate the two, even if the pharmacological interaction itself turns out to be minor. If you feel unusually drowsy, confused, or uncoordinated after taking ivermectin, you want to be able to identify that as a potential drug effect rather than assuming it is just the alcohol.

The Alcohol Use Disorder Connection

In an interesting twist, researchers have explored whether ivermectin might help treat alcohol dependence. The rationale stems from ivermectin’s effect on a specific class of brain receptors called purinergic P2X4 receptors, which are involved in alcohol’s rewarding effects. By modulating these receptors, ivermectin could theoretically reduce the pleasurable response to drinking, dampening the cycle of craving and reward that drives alcohol use disorder. The pilot study mentioned earlier tested this hypothesis at a 30 mg daily dose, finding that ivermectin was safe alongside alcohol but did not, at that dose, reduce craving or the reinforcing effects of drinking.²

This line of research is still early, and the fact that it exists speaks to an unusual aspect of ivermectin’s pharmacology: it interacts with several receptor systems in the mammalian brain, not just the ones that make it useful against parasites. Those broader interactions are precisely why the combination with alcohol deserves more scrutiny than it has received, even as the existing safety data is modestly reassuring. The science here is thin, shaped more by the absence of large-scale harm signals than by thorough investigation. For a drug that hundreds of millions of people take each year in mass drug administration programs, the lack of widespread reports of alcohol-ivermectin interactions is itself a data point, just not a definitive one.